MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 256 filers reported holding MIRATI THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,046,665 | +45.3% | 46,985 | +20.5% | 0.00% | – |
| Q2 2023 | $1,408,745 | -5.8% | 38,991 | -3.1% | 0.00% | -100.0% |
| Q1 2023 | $1,495,938 | -6.1% | 40,235 | +14.4% | 0.00% | 0.0% |
| Q4 2022 | $1,593,054 | -37.1% | 35,159 | -3.0% | 0.00% | 0.0% |
| Q3 2022 | $2,532,000 | -1.8% | 36,255 | -5.6% | 0.00% | 0.0% |
| Q2 2022 | $2,578,000 | -19.0% | 38,397 | -0.8% | 0.00% | 0.0% |
| Q1 2022 | $3,181,000 | -40.3% | 38,691 | +6.5% | 0.00% | -50.0% |
| Q4 2021 | $5,331,000 | -19.4% | 36,338 | -2.8% | 0.00% | 0.0% |
| Q3 2021 | $6,616,000 | +40.8% | 37,401 | +28.5% | 0.00% | 0.0% |
| Q2 2021 | $4,700,000 | -0.2% | 29,095 | +5.9% | 0.00% | 0.0% |
| Q1 2021 | $4,709,000 | -23.4% | 27,487 | -1.8% | 0.00% | 0.0% |
| Q4 2020 | $6,151,000 | +63.0% | 28,001 | +23.2% | 0.00% | 0.0% |
| Q3 2020 | $3,774,000 | +45.4% | 22,723 | -0.0% | 0.00% | +100.0% |
| Q2 2020 | $2,595,000 | +57.4% | 22,728 | +6.0% | 0.00% | 0.0% |
| Q1 2020 | $1,649,000 | -27.0% | 21,450 | +22.4% | 0.00% | 0.0% |
| Q4 2019 | $2,259,000 | +76.1% | 17,530 | +6.5% | 0.00% | 0.0% |
| Q3 2019 | $1,283,000 | +144.4% | 16,463 | +223.2% | 0.00% | – |
| Q2 2019 | $525,000 | +75.6% | 5,093 | +24.6% | 0.00% | – |
| Q1 2019 | $299,000 | +94.2% | 4,089 | +12.5% | 0.00% | – |
| Q4 2018 | $154,000 | +4.8% | 3,635 | +16.5% | 0.00% | – |
| Q3 2018 | $147,000 | -2.0% | 3,120 | +2.6% | 0.00% | – |
| Q2 2018 | $150,000 | +689.5% | 3,042 | -19.7% | 0.00% | – |
| Q1 2017 | $19,000 | +5.6% | 3,790 | 0.0% | 0.00% | – |
| Q4 2016 | $18,000 | +20.0% | 3,790 | +70.0% | 0.00% | – |
| Q3 2016 | $15,000 | +25.0% | 2,230 | 0.0% | 0.00% | – |
| Q2 2016 | $12,000 | -75.0% | 2,230 | 0.0% | 0.00% | – |
| Q1 2016 | $48,000 | -30.4% | 2,230 | 0.0% | 0.00% | – |
| Q4 2015 | $69,000 | – | 2,230 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |